Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients

NCT01610141 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Deep Vein Thrombosis
Pulmonary Embolism
Heart Valve Disease

Interventions

OTHER: Genotype-guided warfarin dosing
OTHER: Non-genotype guided warfarin dosing

Sponsor

Chinese PLA General Hospital